| For: | Zhu WJ, Da YW, Chen H, Xu M, Lu Y, Di L, Duo JY. Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports . World J Clin Cases 2022; 10(5): 1709-1715 [PMID: 35211613 DOI: 10.12998/wjcc.v10.i5.1709] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i5/1709.htm |
| Number | Citing Articles |
| 1 |
Meng-ge Yang, Li Xu, Suqiong Ji, Huajie Gao, Qing Zhang, Bitao Bu. Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins. Neuropsychiatric Disease and Treatment 2022; doi: 10.2147/NDT.S361461
|
| 2 |
Li Di, Xinmei Wen, Wenjia Zhu, Min Wang, Yan Lu, Min Xu, Hai Chen, Yuwei Da. Efficacy of Tacrolimus Plus Prednisone as Long-Term Immunosuppressive Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: A Retrospective Cohort Study. ImmunoTargets and Therapy 2025; doi: 10.2147/ITT.S536989
|
| 3 |
Yujia Shen, Jianian Hu, Chong Sun, Yiyun Huang, Heting Cai, Kuan Liu, Xinyue Huang, Jian Sun, Yanyin Zhao, Chongbo Zhao, Jie Lin. Transitioning from efgartigimod to tacrolimus in chronic inflammatory demyelinating polyneuropathy: a prospective case series. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1916815
|
| 4 |
|